Vaccine Contract Manufacturing Market Report

Global and Region Vaccine Contract Manufacturing Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：163
  • REPORT CODE：GMM1000686
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Vaccine Contract Manufacturing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Vaccine Contract Manufacturingmarket, defines the market attractiveness level of Vaccine Contract Manufacturing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Vaccine Contract Manufacturing industry, describes the types of Vaccine Contract Manufacturing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Vaccine Contract Manufacturing market and the development prospects and opportunities of Vaccine Contract Manufacturing industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Vaccine Contract Manufacturing market in Chapter 13.

    By Player:

    • Mereck KGaA (Germany)

    • Fujifilm Diosynth Biotechnologies USA, Inc

    • Merck KGaA

    • Lonza

    • Catalent, Inc

    • Pfizer Inc (US)

    • Servier Laboratories (France)

    • Cytovance Biologics

    • Ajinomoto Althea, Inc

    By Type:

    • Attenuated Vaccine

    • Inactivated Vaccine

    • Subunit vaccines

    • Toxoid Vaccines

    • DNA Vaccines

    By End-User:

    • Pharmaceutical Companies

    • Biotech Companies

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Vaccine Contract Manufacturing Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Vaccine Contract Manufacturing Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Vaccine Contract Manufacturing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Vaccine Contract Manufacturing Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Vaccine Contract Manufacturing Market Analysis and Outlook to 2022

    • 7.1 Global Vaccine Contract Manufacturing Consumption (2017-2022)

    • 7.2 United States Vaccine Contract Manufacturing Consumption (2017-2022)

    • 7.3 Europe Vaccine Contract Manufacturing Consumption (2017-2022)

    • 7.4 China Vaccine Contract Manufacturing Consumption (2017-2022)

    • 7.5 Japan Vaccine Contract Manufacturing Consumption (2017-2022)

    • 7.6 India Vaccine Contract Manufacturing Consumption (2017-2022)

    • 7.7 South Korea Vaccine Contract Manufacturing Consumption (2017-2022)

    8 Region and Country-wise Vaccine Contract Manufacturing Market Analysis and Outlook to 2028

    • 8.1 Global Vaccine Contract Manufacturing Consumption Forecast (2022-2028)

    • 8.2 United States Vaccine Contract Manufacturing Consumption Forecast (2022-2028)

    • 8.3 Europe Vaccine Contract Manufacturing Consumption Forecast (2022-2028)

    • 8.4 China Vaccine Contract Manufacturing Consumption Forecast (2022-2028)

    • 8.5 Japan Vaccine Contract Manufacturing Consumption Forecast (2022-2028)

    • 8.6 India Vaccine Contract Manufacturing Consumption Forecast (2022-2028)

    • 8.7 South Korea Vaccine Contract Manufacturing Consumption Forecast (2022-2028)

    9 Global Vaccine Contract Manufacturing Market Outlook by Types and Applications to 2022

    • 9.1 Global Vaccine Contract Manufacturing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Attenuated Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Inactivated Vaccine Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Subunit vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Toxoid Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global DNA Vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Vaccine Contract Manufacturing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Biotech Companies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Vaccine Contract Manufacturing Market Outlook by Types and Applications to 2028

    • 10.1 Global Vaccine Contract Manufacturing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Attenuated Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Subunit vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Toxoid Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global DNA Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Vaccine Contract Manufacturing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Biotech Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Vaccine Contract Manufacturing Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Vaccine Contract Manufacturing Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Vaccine Contract Manufacturing Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Vaccine Contract Manufacturing Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Vaccine Contract Manufacturing Market Competitive Analysis

    • 14.1 Mereck KGaA (Germany)

      • 14.1.1 Mereck KGaA (Germany) Company Details

      • 14.1.2 Mereck KGaA (Germany) Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Mereck KGaA (Germany) Vaccine Contract Manufacturing Product and Service

    • 14.2 Fujifilm Diosynth Biotechnologies USA, Inc

      • 14.2.1 Fujifilm Diosynth Biotechnologies USA, Inc Company Details

      • 14.2.2 Fujifilm Diosynth Biotechnologies USA, Inc Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Fujifilm Diosynth Biotechnologies USA, Inc Vaccine Contract Manufacturing Product and Service

    • 14.3 Merck KGaA

      • 14.3.1 Merck KGaA Company Details

      • 14.3.2 Merck KGaA Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Merck KGaA Vaccine Contract Manufacturing Product and Service

    • 14.4 Lonza

      • 14.4.1 Lonza Company Details

      • 14.4.2 Lonza Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Lonza Vaccine Contract Manufacturing Product and Service

    • 14.5 Catalent, Inc

      • 14.5.1 Catalent, Inc Company Details

      • 14.5.2 Catalent, Inc Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Catalent, Inc Vaccine Contract Manufacturing Product and Service

    • 14.6 Pfizer Inc (US)

      • 14.6.1 Pfizer Inc (US) Company Details

      • 14.6.2 Pfizer Inc (US) Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Inc (US) Vaccine Contract Manufacturing Product and Service

    • 14.7 Servier Laboratories (France)

      • 14.7.1 Servier Laboratories (France) Company Details

      • 14.7.2 Servier Laboratories (France) Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Servier Laboratories (France) Vaccine Contract Manufacturing Product and Service

    • 14.8 Cytovance Biologics

      • 14.8.1 Cytovance Biologics Company Details

      • 14.8.2 Cytovance Biologics Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Cytovance Biologics Vaccine Contract Manufacturing Product and Service

    • 14.9 Ajinomoto Althea, Inc

      • 14.9.1 Ajinomoto Althea, Inc Company Details

      • 14.9.2 Ajinomoto Althea, Inc Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Ajinomoto Althea, Inc Vaccine Contract Manufacturing Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Vaccine Contract Manufacturing

    • Figure Vaccine Contract Manufacturing Picture

    • Table Global Vaccine Contract Manufacturing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Vaccine Contract Manufacturing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Vaccine Contract Manufacturing Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Vaccine Contract Manufacturing Consumption by Country (2017-2022)

    • Figure United States Vaccine Contract Manufacturing Consumption and Growth Rate (2017-2022)

    • Table Europe Vaccine Contract Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure China Vaccine Contract Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Japan Vaccine Contract Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure India Vaccine Contract Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Vaccine Contract Manufacturing Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccine Contract Manufacturing Consumption Forecast by Country (2022-2028)

    • Figure United States Vaccine Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Vaccine Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Vaccine Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Vaccine Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Vaccine Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Vaccine Contract Manufacturing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Attenuated Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Inactivated Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Subunit vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Toxoid Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global DNA Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Biotech Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Attenuated Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Subunit vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Toxoid Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DNA Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biotech Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Vaccine Contract Manufacturing Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Vaccine Contract Manufacturing Export by Region (Top 5 Countries) (2017-2028)

    • Table Mereck KGaA (Germany) (Foundation Year, Company Profile and etc.)

    • Table Mereck KGaA (Germany) Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mereck KGaA (Germany) Vaccine Contract Manufacturing Product and Service

    • Table Fujifilm Diosynth Biotechnologies USA, Inc (Foundation Year, Company Profile and etc.)

    • Table Fujifilm Diosynth Biotechnologies USA, Inc Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fujifilm Diosynth Biotechnologies USA, Inc Vaccine Contract Manufacturing Product and Service

    • Table Merck KGaA (Foundation Year, Company Profile and etc.)

    • Table Merck KGaA Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck KGaA Vaccine Contract Manufacturing Product and Service

    • Table Lonza (Foundation Year, Company Profile and etc.)

    • Table Lonza Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lonza Vaccine Contract Manufacturing Product and Service

    • Table Catalent, Inc (Foundation Year, Company Profile and etc.)

    • Table Catalent, Inc Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Catalent, Inc Vaccine Contract Manufacturing Product and Service

    • Table Pfizer Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc (US) Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc (US) Vaccine Contract Manufacturing Product and Service

    • Table Servier Laboratories (France) (Foundation Year, Company Profile and etc.)

    • Table Servier Laboratories (France) Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Servier Laboratories (France) Vaccine Contract Manufacturing Product and Service

    • Table Cytovance Biologics (Foundation Year, Company Profile and etc.)

    • Table Cytovance Biologics Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cytovance Biologics Vaccine Contract Manufacturing Product and Service

    • Table Ajinomoto Althea, Inc (Foundation Year, Company Profile and etc.)

    • Table Ajinomoto Althea, Inc Vaccine Contract Manufacturing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ajinomoto Althea, Inc Vaccine Contract Manufacturing Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US